Description: Cell MedX Corp. is a development-stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases, such as diabetes, by developing technologies to help manage the illness and related complications. The Company, through its subsidiary, Avyonce Cosmedics Inc. (Avyonce), is engaged in reselling and marketing spa technology and equipment to the beauty and wellness industry. Avyonce is involved in carrying out observational studies using eBalance Technology. The eBalance Technology is used for the use of micro currents for the treatment of diabetes and related ailments. Avyonce also provides continuing education to the estheticians and healthcare professionals in the field of medical aesthetics. The Company is engaged in developing a family of devices based on the eBalance Technology.
Home Page: www.cellmedx.com
123 West Nye Ln
Carson City,
NV
89706
United States
Phone:
844 238 2692
Officers
| Name | Title |
|---|---|
| Ms. Yanika Silina C.M.A., CPA | CFO, Treasurer, Corp. Sec. & Director |
| Mr. Joao da Costa | COO & Director |
| Mr. Bradley S. Hargreaves | VP of Technology & Operations and Director |
| Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | MD & Independent Director |
| Mr. Dwayne Yaretz | CEO & Director |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 591.5846 |
| IPO Date: | |
| Fiscal Year End: | May |
| Full Time Employees: | 0 |